Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Increased β-Lactams dosing regimens improve clinical outcome in critically ill patients with augmented renal clearance treated for a first episode of hospital or ventilator-acquired pneumonia: a before and after study

Fig. 2

Cumulative incidence of therapeutic failure or HAP-VAP relapse among the IPTW pseudo-cohort treated by conventional (control group; full line) or increased (treatment group; dotted line) β-lactam dosing regimens. Data adjusted on propensity score, SAPS 2 and PaO2/FiO2 ratio

Back to article page